Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.
Source: MedicalNewsToday.com
Mesothelioma shows promising response to existing immunotherapy drug
Published in Health News
More from Health NewsMore posts in Health News »
- Researcher Studies How Messaging On COVID-19 Disparities Affects Policy Preferences
- Half of U.S. adults have received at least one Covid shot in milestone for vaccination campaign
- UK scientists launch human challenge trial to study Covid reinfection
- COVID Deaths Higher With Neuro Syndromes in Hospitalized Patients
- ‘That’s Not Spin, That’s Stats’: What We Heard This Week
